Moderna claims its scientists alone invented the mRNA sequence used to produce its COVID-19 vaccine. The US government, which helped fund the drug, disagrees.
Articles on Moderna
Displaying 21 - 40 of 69 articles
Properly engaged and monitored, Nigeria’s private sector can do more in COVID vaccination exercise.
Protection from infection wanes over time. So boosters will offer extra protection and hopefully reduce the spread of the virus even further.
As boosters are authorized for all three COVID-19 shots available in the US, the ability to swap out vaccine types looks to be a boon to the immune system.
There are very few situations where someone can’t have a COVID vaccine for medical reasons.
A medical student answers questions he gets asked at a COVID-19 vaccine clinic: Efficacy versus real-world effectiveness, immune response and how the mRNA vaccines compare to vaccines already in wide use.
University of Canberra Professorial Fellow Michelle Grattan and University of Canberra Associate Professor Caroline Fisher discuss the week in politics.
Doses of the Moderna vaccine will be available in Australia from mid-September. So if you’re in an eligible group you could be offered either Pfizer or Moderna. Here’s how they compare.
The Moderna vaccine has been provisionally approved by the Therapeutic Goods Administration for use in Australia, with one million doses due in the second half of September, which will go to pharmacies.
As Los Angeles County again mandates masking indoors – even for the fully vaccinated – local health officials in the U.S. are closely eyeing their own COVID-19 vaccination and infection rates.
As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.
If Big Pharma wants to achieve the ultimate image makeover, it must capitalize on the current public good will about its COVID-19 vaccines by prioritizing socially responsible practices.
This myth is still circulating online. Here’s why the chance of this happening is next to zero.
Even if we came up with a definition of what makes the “best” vaccine, we don’t have the luxury of choice, when vaccines are in short supply.
A vaccine expert breaks down everything you need to know about Australia’s newest COVID-19 vaccine candidate.
This week’s budget assumes all Australians will have the chance to be fully vaccinated by the end of the year. It’s ambitious but possible.
Canadian public health organizations have run into a serious communication problem about the AstraZeneca vaccine. Crisis management and communication theories explain what’s gone wrong.
The anticipated arrival of two new vaccines can boost the morale of those worried about the wait for their dose.
So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how do they work? What are their weaknesses? Five experts explain.
The coronavirus pandemic has driven a lot of scientific progress in the past year. But just as some of the social changes are likely here to stay, so are some medical innovations.
Top contributors
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor of Microbiology, School of Medicine, University of Washington
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Professor of Law, Villanova University
-
Professor, The Children's Hospital at Westmead Clinical School and Sydney Infectious Diseases Institute, University of Sydney
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Associate Professor, School of Professional Communication, Toronto Metropolitan University
-
Professorial Fellow, University of Canberra
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Part-time lecturer at the Global Health & Social Medicine, Harvard University, and Lecturer at the School of Public Health, College of Health Sciences, University of Liberia
-
Paediatrician and Clinical Senior Lecturer, Children's Hospital Westmead Clinical School, University of Sydney
-
Senior Research Fellow, Population Interventions Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne